Onward® medical announces publication highlighting evidence-based programming for arc-ex® therapy

Framework to determine stimulation parameters for onward arc-ex therapy are published in the journal neuromodulation: technology at the neural interface peer-reviewed publication is based on results from the up-lift and lift home studies eindhoven, the netherlands, july 09, 2024 (globe newswire) -- onward medical n.v. (euronext: onwd), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (sci), today announces a publication in neuromodulation: technology at the neural interface , summarizing effective stimulation parameters from the up-lift and lift home studies and providing a decision-making framework for clinical implementation of onward arc-ex therapy created by study investigators.
ARC Ratings Summary
ARC Quant Ranking